Navigation Links
NREL uses industry best practices to add partners
Date:8/6/2014

pilot for using DOE's newest agreement type: the Agreement to Commercialize Technology (ACT). NREL is one of six national laboratories currently piloting the use of ACT, which was created to address requests by industry for flexibility in partnership agreement terms beyond what is available under a CRADA or work-for-others (WFO) agreement.

Anne Miller of NREL's Technology Transfer Office noted two of the most recent agreements with NREL developed out of opportunities that would most likely not have been available if ACTs were not an option.

Because ACTs are aligned with industry practices in areas such as intellectual property rights, indemnification, and payment issues, these agreements allow national laboratories such as NREL to more easily negotiate contract terms with potential partners to accommodate unique organizational requirements or project needs.

"For example, a company may need special provisions to address participation by multiple organizations or expectations regarding project performance," Miller said. "ACTs allow us to negotiate terms with much more flexibility than the standard agreement types and also allow us to pursue some opportunities we might not otherwise have been able to pursue."

Under NREL's first ACT, the lab will supply technical services to the International Renewable Energy Agency (IRENA), an intergovernmental organization that supports countries in their transition to a sustainable energy future. Signed on March 7, 2014, IRENA's ACT with NREL outlines how the laboratory will develop computer code for IRENA's geospatial data interface of the Global Atlas for Renewable Energy, which will support renewable energy technology project development, planning, siting, and feasibility analysis.

NREL's second ACT was signed with the Children's Investment Fund Foundation (CIFF), which aims to improve the lives of children in developing countries through impactful and sustainable projects. Under this
'/>"/>

Contact: David Glickson
david.glickson@nrel.gov
303-275-4097
DOE/National Renewable Energy Laboratory
Source:Eurekalert

Page: 1 2 3 4 5 6

Related biology news :

1. Gray seals consume as much fish as the fishing industry catches
2. Saving forests? Take a leaf from insurance industrys book
3. Global Laboratory Automation Industry
4. How will the US biotechnology industry benefit from new patent laws?
5. NIST launches new website to educate industry about alternatives to mercury thermometers
6. Work starts on fossil fuel free cargo ship set to transform shipping industry
7. Pilot Results Move GHX Closer to Delivery of Healthcare Industrys First Implantable Device Supply Chain Solution
8. Food industrys high-quality co-streams used effectively as raw material for new products
9. Remarkable enzyme points the way to reducing nitric acid use in industry
10. Crank Software Selects TREW Marketing for Embedded Industry Outreach
11. Plastic packaging industry is moving towards completely bio-based products
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/10/2015)... 10, 2015 Research and Markets ... "Security Competitive Profiles - NEC" report to ... NEC will continue to supply a range of ... with a company focus on the development of a ... Winning opportunities in the Asia-Pacific ...
(Date:4/2/2015)... 2, 2015 In the ... far outperforms the strongest competitors, showing outstanding performance ... the system is capable of a throughput of ... up to be ten times faster than most ... performance.      (Photo: http://photos.prnewswire.com/prnh/20150402/738673-a ...
(Date:4/1/2015)... -- NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or the ... mobile commerce market, announces the second shipment of a ... early access pre-order customers. Feedback from ... including Walmart, Target, AT&T, Dunkin, Donuts, Stop & Shop ... all outlets and very easy to use. Several users ...
Breaking Biology News(10 mins):NEC Security Competitive Profile 2015 2DERMALOG AFIS Emerges as Performance Winner in NIST Benchmark Test 2DERMALOG AFIS Emerges as Performance Winner in NIST Benchmark Test 3NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 2NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 3NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 4
... Medicine uses PET, radiotracer to track enzyme in smokers, ... in the lungs, possibly contributing to some of smoking's ... the September issue of the Journal of Nuclear Medicine. ... enzyme, also shows that smokers had a lower concentration ...
... of Pennsylvania School of Medicine found that a protein ... development of hematopoietic stem cells (HSC), or blood-producing stem ... pathway may one day lead to new treatments for ... better understanding of how HSCs work in the context ...
... A new study of 60 beaches in Southern California ... reaching the highest levels when tides are ebbing during ... beachgoers and managers better assess the potential risk of ... issue of the American Chemical Society's journal Environmental Science ...
Cached Biology News:Smoking damages key regulatory enzyme in the lung 2Smoking damages key regulatory enzyme in the lung 3Master regulatory gene found that guides fate of blood-producing stem cells 2Beach pollution is worst during new and full moon 2
(Date:4/16/2015)... April 16, 2015 Cytokinetics, Incorporated (Nasdaq: ... first quarter results on Thursday, April 30, 2015 at ... management will host a conference call at 4:30 PM ... the company’s outlook for the future. , The conference ... from the homepage and in the Investor Relations section ...
(Date:4/16/2015)... Proove Biosciences , Inc. is ... Contest for the 2015 BIO International Convention. Hosted ... International Convention will take place June 15-18 at the ... of BIO contest, industry leaders will be voting for ... conference. The community voting period began on April 14, ...
(Date:4/16/2015)... (PRWEB) April 16, 2015 Regis Technologies ... American Association for Cancer Research (AACR) annual meeting. Regis ... Convention Center, starting Saturday, April 18, in Philadelphia and ... claim to title of the oldest and largest organization ... fellowships and grants, and partners with survivors to promote ...
(Date:4/16/2015)... (PRWEB) April 16, 2015 ... at Charlotte (UNC Charlotte) spin-out company, announced today ... Cooper, Ph.D., M.D., as Chief Operating Officer (COO). ... of experience in developing clinical diagnostic and biotechnology ... infectious disease. , Cooper’s extensive career transcends the ...
Breaking Biology Technology:Cytokinetics to Announce First Quarter Results on April 30, 2015 2Cytokinetics to Announce First Quarter Results on April 30, 2015 3Proove Bisociences to Participate in the Buzz of BIO at the 2015 BIO International Convention 2Proove Bisociences to Participate in the Buzz of BIO at the 2015 BIO International Convention 3Regis Technologies Joins American Association for Cancer Research Annual Meeting 2OncoTAb Names Dr. David L. Cooper as COO 2
... LAKES, N.J., June 1 BD (Becton, Dickinson and Company) (NYSE: BDX ), ... healthcare conferences in June: , , Goldman Sachs ... 11:40 a.m. EDT, ... June 11, 2009, 10:00 a.m. EDT, , ...
... ARBOR, Mich., June 1 Assay Designs, Inc., a ... the life science and translational research markets, has announced ... dedicated to the analysis of heat shock proteins and ... , The bead-based multiplex immunoassay enables measurement of ...
... Pharmaceuticals Corp. ("Raptor" or the "Company") (OTC Bulletin ... the first patient in its Phase 2b clinical ... of California, San Diego ("UCSD"), to evaluate ... in nephropathic cystinosis ("cystinosis"), a rare genetic lysosomal ...
Cached Biology Technology:Assay Designs(TM), Inc. Announces Release of First Available Product for Multiplex Analysis of Heat Shock Proteins 2Raptor Pharmaceuticals Doses First Patient in Phase 2b Clinical Trial of DR Cysteamine for Cystinosis 2Raptor Pharmaceuticals Doses First Patient in Phase 2b Clinical Trial of DR Cysteamine for Cystinosis 3Raptor Pharmaceuticals Doses First Patient in Phase 2b Clinical Trial of DR Cysteamine for Cystinosis 4Raptor Pharmaceuticals Doses First Patient in Phase 2b Clinical Trial of DR Cysteamine for Cystinosis 5
Originally developed for the culture of Drosophila; suitable for culture of other dipteran cell lines. Powder, Insect cell culture tested...
... number is a new product ... Cornings product number. If showing ... under the old Sigma-Aldrich number ... for assistance. Mfr Desig: ...
... polystyrene with frosted labeling surfaces, volume ... counting. 100% integrity tested. Linkage: This ... number, created to easily match Cornings ... yet, please order under the old ...
... ® Ek Adaptor encodes a T7 ... site (rbs), ATG translation initation codon, and ... is a small epitope tag (11 aa) ... target protein with T7•Tag Monoclonal Antibody and ...
Biology Products: